BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29973652)

  • 1. Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association.
    Palsgrove DN; Brosnan-Cashman JA; Giannini C; Raghunathan A; Jentoft M; Bettegowda C; Gokden M; Lin D; Yuan M; Lin MT; Heaphy CM; Rodriguez FJ
    Mod Pathol; 2018 Dec; 31(12):1787-1800. PubMed ID: 29973652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations.
    Liu XY; Gerges N; Korshunov A; Sabha N; Khuong-Quang DA; Fontebasso AM; Fleming A; Hadjadj D; Schwartzentruber J; Majewski J; Dong Z; Siegel P; Albrecht S; Croul S; Jones DT; Kool M; Tonjes M; Reifenberger G; Faury D; Zadeh G; Pfister S; Jabado N
    Acta Neuropathol; 2012 Nov; 124(5):615-25. PubMed ID: 22886134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia.
    Rodriguez FJ; Brosnan-Cashman JA; Allen SJ; Vizcaino MA; Giannini C; Camelo-Piragua S; Webb M; Matsushita M; Wadhwani N; Tabbarah A; Hamideh D; Jiang L; Chen L; Arvanitis LD; Alnajar HH; Barber JR; Rodríguez-Velasco A; Orr B; Heaphy CM
    Brain Pathol; 2019 Jan; 29(1):126-140. PubMed ID: 30192422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.
    Ferreira MSV; Sørensen MD; Pusch S; Beier D; Bouillon AS; Kristensen BW; Brümmendorf TH; Beier CP; Beier F
    J Neurooncol; 2020 Mar; 147(1):1-14. PubMed ID: 31960234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic variations in NF1-associated low grade astrocytomas: possible role for increased mTOR activation in a subset.
    Jentoft M; Giannini C; Cen L; Scheithauer BW; Hoesley B; Sarkaria JN; Abell-Aleff PC; Rodriguez EF; Li Y; Rodriguez FJ
    Int J Clin Exp Pathol; 2010 Dec; 4(1):43-57. PubMed ID: 21228927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on the central nervous system manifestations of neurofibromatosis type 1.
    Nix JS; Blakeley J; Rodriguez FJ
    Acta Neuropathol; 2020 Apr; 139(4):625-641. PubMed ID: 30963251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMARCAL1 loss and alternative lengthening of telomeres (ALT) are enriched in giant cell glioblastoma.
    Brosnan-Cashman JA; Davis CM; Diplas BH; Meeker AK; Rodriguez FJ; Heaphy CM
    Mod Pathol; 2021 Oct; 34(10):1810-1819. PubMed ID: 34103668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas.
    Nguyen DN; Heaphy CM; de Wilde RF; Orr BA; Odia Y; Eberhart CG; Meeker AK; Rodriguez FJ
    Brain Pathol; 2013 May; 23(3):237-43. PubMed ID: 22928601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
    Reinhardt A; Stichel D; Schrimpf D; Sahm F; Korshunov A; Reuss DE; Koelsche C; Huang K; Wefers AK; Hovestadt V; Sill M; Gramatzki D; Felsberg J; Reifenberger G; Koch A; Thomale UW; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Mueller W; Tuffaha MSA; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Monoranu CM; Kessler AF; Loehr M; Buslei R; Deckert M; Mawrin C; Kohlhof P; Hewer E; Olar A; Rodriguez FJ; Giannini C; NageswaraRao AA; Tabori U; Nunes NM; Weller M; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Jones DTW; von Deimling A; Capper D
    Acta Neuropathol; 2018 Aug; 136(2):273-291. PubMed ID: 29564591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas.
    Abedalthagafi M; Phillips JJ; Kim GE; Mueller S; Haas-Kogen DA; Marshall RE; Croul SE; Santi MR; Cheng J; Zhou S; Sullivan LM; Martinez-Lage M; Judkins AR; Perry A
    Mod Pathol; 2013 Nov; 26(11):1425-32. PubMed ID: 23765250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model of a patient-derived IDH1 mutant anaplastic astrocytoma with alternative lengthening of telomeres.
    Borodovsky A; Meeker AK; Kirkness EF; Zhao Q; Eberhart CG; Gallia GL; Riggins GJ
    J Neurooncol; 2015 Feb; 121(3):479-87. PubMed ID: 25471051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of H3K27M mutation with specific histomorphological features and associated molecular alterations in pediatric high-grade glial tumors.
    Bozkurt SU; Dagcinar A; Tanrikulu B; Comunoglu N; Meydan BC; Ozek M; Oz B
    Childs Nerv Syst; 2018 Jan; 34(1):107-116. PubMed ID: 29063957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular landscape of glioma in patients with Neurofibromatosis 1.
    D'Angelo F; Ceccarelli M; Tala ; Garofano L; Zhang J; Frattini V; Caruso FP; Lewis G; Alfaro KD; Bauchet L; Berzero G; Cachia D; Cangiano M; Capelle L; de Groot J; DiMeco F; Ducray F; Farah W; Finocchiaro G; Goutagny S; Kamiya-Matsuoka C; Lavarino C; Loiseau H; Lorgis V; Marras CE; McCutcheon I; Nam DH; Ronchi S; Saletti V; Seizeur R; Slopis J; Suñol M; Vandenbos F; Varlet P; Vidaud D; Watts C; Tabar V; Reuss DE; Kim SK; Meyronet D; Mokhtari K; Salvador H; Bhat KP; Eoli M; Sanson M; Lasorella A; Iavarone A
    Nat Med; 2019 Jan; 25(1):176-187. PubMed ID: 30531922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1.
    Cimino PJ; Ketchum C; Turakulov R; Singh O; Abdullaev Z; Giannini C; Pytel P; Lopez GY; Colman H; Nasrallah MP; Santi M; Fernandes IL; Nirschl J; Dahiya S; Neill S; Solomon D; Perez E; Capper D; Mani H; Caccamo D; Ball M; Badruddoja M; Chkheidze R; Camelo-Piragua S; Fullmer J; Alexandrescu S; Yeaney G; Eberhart C; Martinez-Lage M; Chen J; Zach L; Kleinschmidt-DeMasters BK; Hefti M; Lopes MB; Nuechterlein N; Horbinski C; Rodriguez FJ; Quezado M; Pratt D; Aldape K
    Acta Neuropathol; 2023 Jan; 145(1):71-82. PubMed ID: 36271929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.
    Kotulska K; Borkowska J; Roszkowski M; Mandera M; Daszkiewicz P; Drabik K; Jurkiewicz E; Larysz-Brysz M; Nowak K; Grajkowska W; Domańska-Pakieła D; Jóźwiak S
    Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of ambiguous differentiation and mTOR pathway dysregulation in subependymal giant cell astrocytoma.
    Barrows BD; Rutkowski MJ; Gültekın SH; Parsa AT; Tıhan T
    Turk Patoloji Derg; 2012; 28(2):95-103. PubMed ID: 22627626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
    Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
    J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid transcription factor-1 distinguishes subependymal giant cell astrocytoma from its mimics and supports its cell origin from the progenitor cells in the medial ganglionic eminence.
    Hang JF; Hsu CY; Lin SC; Wu CC; Lee HJ; Ho DM
    Mod Pathol; 2017 Mar; 30(3):318-328. PubMed ID: 27910945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
    Romo CG; Piotrowski AF; Campian JL; Diarte J; Rodriguez FJ; Bale TA; Dahiya S; Gutmann DH; Lucas CG; Prichett L; Mellinghoff I; Blakeley JO
    Neuro Oncol; 2023 Aug; 25(8):1474-1486. PubMed ID: 36840626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
    Reuss DE; Sahm F; Schrimpf D; Wiestler B; Capper D; Koelsche C; Schweizer L; Korshunov A; Jones DT; Hovestadt V; Mittelbronn M; Schittenhelm J; Herold-Mende C; Unterberg A; Platten M; Weller M; Wick W; Pfister SM; von Deimling A
    Acta Neuropathol; 2015 Jan; 129(1):133-46. PubMed ID: 25427834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.